New radioactive tracer for PET scanning
Positron emission tomography (PET) is a type of medical imaging technique in which radioactive tracers are introduced into the body to allow doctors to detect and measure physiological processes such as inflammation, blood flow and tumour growth. For inflammation, one of the most commonly used tracers is 18F-FDG (fluorodeoxyglucose), but because this tracer labels a variety of metabolically active cells, it lacks specificity. Now, there’s a new tracer in the works: a radioactive version of a natural molecule – Siglec-9 – that binds the inflammatory protein vascular adhesion protein 1. And, the tracer’s greater specificity means it could be used at lower doses and have improved accuracy. Indeed, the hands of the rheumatoid arthritis patient pictured appear to show brighter signals at the inflamed joints when Siglec-9 was used for PET (top) than when 18F-FDG was used (bottom). Such results in early human testing bode well for the tracer’s continued clinical development.
BPoD stands for Biomedical Picture of the Day. Managed by the MRC London Institute of Medical Sciences the website aims to engage everyone, young and old, in the wonders of biomedicine. Images are kindly provided for inclusion on this website through the generosity of scientists across the globe.
BPoD is also available in Catalan at www.bpod.cat with translations by the University of Valencia.